Home Daily Tape Research Hub About Subscribe

Join 2,000+ investors

The biotech deal tape in your inbox. Free.

✓Top news, M&A, BD&L, IPOs and VC — every morning
✓Deal economics with investor-grade context
✓Research Hub access: live trackers updated weekly
✓5 minutes. Published every weekday.

Recent editions

Jul 24, 2026

Friday: Lilly's triple-G lands 22.6% and misses on MACE

Retatrutide clears the bar but not the one that mattered, J&J posts an 0.11, and gene editing prices an IPO.

Jul 23, 2026

Thursday: GSK's $10.6B Nuvalent bet pays off in a week

FDA cleared GSK's $10.6B Nuvalent asset two months early. Arrowhead cut triglycerides 81%.

Jul 22, 2026

Wednesday: Trump starts a 200% tariff clock on foreign generics

Novo drags Lilly to court over GLP-1 ads, Agios quits a sickle cell shot, and Dyne still banks $375M.

Daily Tape Research Hub About Subscribe Privacy

© 2026 BioBucks